Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

The US guidelines are likely to change following the release of the VANISH2 results last year, Christine Albert anticipates.

Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

Rates of arrhythmic events and death remained common in patients indicated for implantable cardioverter defibrillator or ...

In the end, there’s no one-size-fits-all solution for treating arrhythmia. The best medication for an irregular heartbeat ...

Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that new ...

Ventricular tachycardia is an abnormally fast ... N-terminal acetylation dysregulation in the heart causes severe arrhythmia and cardiomyopathy. The authors show that stem cell models demonstrate ...

Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation System will be featured in eight scientific presentations at the 46th annual ...

A brisk walking pace, and the amount of time spent at this speed, may lower the risk of heart rhythm abnormalities, such as atrial fibrillation, tachycardia (rapid heartbeat), and bradycardia ...